beatandraise : SEC Filings Research with AI

beatandraise.com

2.2.0.25falsefalse005000 - Disclosure - Acquisition of King Pharmaceuticals Inc (Table)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 4/3/2011 USD ($) USD ($) / shares $Cur_3mos_20110403http://www.sec.gov/CIK0000078003duration2011-01-01T00:00:002011-04-03T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDperShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PercentStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0us-gaap_BusinessCombinationsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseAcquisition of King Pharmaceuticals Inc [Abstract]3false0us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes the provisional recording, primarily at fair value, of the assets acquired and liabilities assumed as of the acquisition date:</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </font> </div> <div> <hr size="2" align="left" width="100%" style="COLOR: black"/> </div> <div align="left"> <table width="100%" cellspacing="0" cellpadding="0" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td style="border-bottom: black 2px solid" valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-VARIANT: small-caps">(millions of dollars)</font> </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" width="14%" align="right" colspan="2"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amounts</font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Recognized as of</font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition Date</font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Provisional)</font> </div> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="14%" colspan="2"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Working capital, excluding inventories</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">210</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">340</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property, plant and equipment</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">413</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Identifiable intangible assets, excluding in-process research and development</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,781</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In-process research and development</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">301</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net tax accounts</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(384</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All other long-term assets and liabilities, net</font> </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114</font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total identifiable net assets</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,775</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Goodwill</font> </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">780</font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td style="border-bottom: black 6px double " valign="bottom" width="84%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net assets acquired/total consideration transferred</font> </div> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="13%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,555</font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> </table> </div> </div> </div>The following table summarizes the provisional recording, primarily at fair value, of the assets acquired and liabilities assumed as of the falsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Topic 805 -SubTopic 20 -Publisher FASB -Number -Article -Subparagraph -Name Accounting Standards Codification -Paragraph 1 -Section 50 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 falsefalseSchedule Of Recognized Identifiable Assets Acquired And Liabilities Assumed As Part Of Business Combination [Text Block]4false0pfe_ScheduleOfBusinessAcquisitionIncludedInConsolidatedStatementsOfIncomeTextBlockpfefalsenadurationSchedule of business combination that is included in the condensed consolidated statement of income from the acquisition...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table presents information for King that is included in Pfizer’s condensed consolidated statement of income from the acquisition date, January 31, 2011, through Pfizer’s first-quarter 2011 domestic and international quarter-ends:</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </font> </div> <div> <hr size="2" align="left" width="100%" style="COLOR: black"/> </div> <div align="left"> <table width="100%" cellspacing="0" cellpadding="0" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td style="border-bottom: black 2px solid" valign="bottom" width="82%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-VARIANT: small-caps">(millions of dollars)</font> </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="16%" align="right" colspan="2"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">King’s Operations </font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in Pfizer’s First </font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 2011 Results</font> </div> </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="82%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="16%" colspan="2"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="82%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenues</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="15%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">224</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td style="border-bottom: black 6px double " valign="bottom" width="82%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss from continuing operations attributable to Pfizer Inc. common shareholders</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(a)</font> </div> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="15%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(69</font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td> </tr> </table> </div> <div align="left"> <table width="100%" cellspacing="0" cellpadding="0" border="0" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="width: 36pt" width="2%"> <div style="text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font> </div> </td> <td width="98%"> <div align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Includes purchase accounting adjustments related to the fair value adjustments for acquisition-date inventory estimated to have been sold ($57 million pre-tax), amortization of identifiable intangible assets acquired from King ($29 million pre-tax) and restructuring and integration costs ($95 million pre-tax).</font> </div> </td> </tr> </table> </div> </div> </div>The following table presents information for King that is included in Pfizer’s condensed consolidated statement of income from the falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringSchedule of business combination that is included in the condensed consolidated statement of income from the acquisition date.No authoritative reference available.falsefalseSchedule Of Business Acquisition Included In Condensed Consolidated Statements Of Income [Text Block]5false0us-gaap_BusinessAcquisitionProFormaInformationTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table presents supplemental pro forma information as if the acquisition of King had occurred on January 1, 2010: </font> <div> <hr size="2" align="left" width="100%" style="COLOR: black"/> </div> </div> <div align="left"> <table width="100%" cellspacing="0" cellpadding="0" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td style="padding-bottom: 2px" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font> </td> <td style="padding-bottom: 2px" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" colspan="6"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pro Forma Consolidated Results</font> </div> </td> <td style="border-bottom: black 2px solid" valign="bottom" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font> </td> <td style="padding-bottom: 2px" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 2px solid" valign="bottom" colspan="6"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font> </div> </td> <td style="border-bottom: black 2px solid" valign="bottom" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td style="border-bottom: black 2px solid" valign="bottom" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-VARIANT: small-caps">(millions of dollars, except per share  data)</font> </div> </td> <td style="text-indent: 0pt; margin-left: 0pt; padding-bottom: 2px; MARGIN-RIGHT: 0pt" valign="bottom" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="right" colspan="2"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 3,</font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font> </div> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="text-indent: 0pt; margin-left: 0pt; padding-bottom: 2px; MARGIN-RIGHT: 0pt" valign="bottom" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="right" colspan="2"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 4,</font> </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </div> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" colspan="2"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" colspan="2"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenues</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="9%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,611</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="9%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,949</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income from continuing operations attributable to Pfizer Inc. common shareholders</font> </div> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="9%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,313</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td valign="bottom" width="9%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,910</font> </td> <td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> <tr> <td style="border-bottom: black 6px double " valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted earnings per share attributable to Pfizer Inc. common shareholders</font> </div> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.29</font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.24</font> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font> </td> </tr> </table> </div> </div> </div>The following table presents supplemental pro forma information as if the acquisition of King had occurred on January 1, 2010: falsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 54 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 55 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph r(2, 3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseSchedule of pro forma information related to the acquisition [Text Block]14Acquisition of King Pharmaceuticals Inc (Table)UnKnownUnKnownUnKnownUnKnownfalsetrue